The  ||| S:0 E:4 ||| DT
complex  ||| S:4 E:12 ||| JJ
role  ||| S:12 E:17 ||| NN
of  ||| S:17 E:20 ||| IN
SIRT6  ||| S:20 E:26 ||| CD
in  ||| S:26 E:29 ||| IN
carcinogenesis  ||| S:29 E:44 ||| CD
SIRT6 ||| S:44 E:49 ||| CD
,  ||| S:49 E:51 ||| ,
a  ||| S:51 E:53 ||| DT
member  ||| S:53 E:60 ||| NN
of  ||| S:60 E:63 ||| IN
the  ||| S:63 E:67 ||| DT
mammalian  ||| S:67 E:77 ||| JJ
sirtuins  ||| S:77 E:86 ||| JJ
family ||| S:86 E:92 ||| NN
,  ||| S:92 E:94 ||| ,
functions  ||| S:94 E:104 ||| NNS
as  ||| S:104 E:107 ||| IN
a  ||| S:107 E:109 ||| DT
mono-ADP-ribosyl  ||| S:109 E:126 ||| JJ
transferase  ||| S:126 E:138 ||| NN
and  ||| S:138 E:142 ||| CC
NAD ||| S:142 E:145 ||| NNP
( ||| S:145 E:146 ||| -LRB-
+ ||| S:146 E:147 ||| NNP
) ||| S:147 E:148 ||| -RRB-
-dependent  ||| S:148 E:159 ||| JJ
deacylase  ||| S:159 E:169 ||| NN
of  ||| S:169 E:172 ||| IN
both  ||| S:172 E:177 ||| DT
acetyl  ||| S:177 E:184 ||| JJ
groups  ||| S:184 E:191 ||| NNS
and  ||| S:191 E:195 ||| CC
long-chain  ||| S:195 E:206 ||| JJ
fatty  ||| S:206 E:212 ||| JJ
acyl  ||| S:212 E:217 ||| JJ
groups ||| S:217 E:223 ||| NNS
.  ||| S:223 E:225 ||| .
SIRT6  ||| S:225 E:231 ||| NNP
regulates  ||| S:231 E:241 ||| VBZ
diverse  ||| S:241 E:249 ||| JJ
cellular  ||| S:249 E:258 ||| JJ
functions  ||| S:258 E:268 ||| NNS
such  ||| S:268 E:273 ||| JJ
as  ||| S:273 E:276 ||| IN
transcription ||| S:276 E:289 ||| NN
,  ||| S:289 E:291 ||| ,
genome  ||| S:291 E:298 ||| JJ
stability ||| S:298 E:307 ||| NN
,  ||| S:307 E:309 ||| ,
telomere  ||| S:309 E:318 ||| JJ
integrity ||| S:318 E:327 ||| NN
,  ||| S:327 E:329 ||| ,
DNA  ||| S:329 E:333 ||| NNP
repair ||| S:333 E:339 ||| NN
,  ||| S:339 E:341 ||| ,
inflammation  ||| S:341 E:354 ||| NN
and  ||| S:354 E:358 ||| CC
metabolic  ||| S:358 E:368 ||| JJ
related  ||| S:368 E:376 ||| JJ
diseases  ||| S:376 E:385 ||| NNS
such  ||| S:385 E:390 ||| JJ
as  ||| S:390 E:393 ||| IN
diabetes ||| S:393 E:401 ||| NN
,  ||| S:401 E:403 ||| ,
obesity  ||| S:403 E:411 ||| NN
and  ||| S:411 E:415 ||| CC
cancer ||| S:415 E:421 ||| NN
.  ||| S:421 E:423 ||| .
In  ||| S:423 E:426 ||| IN
this  ||| S:426 E:431 ||| DT
review ||| S:431 E:437 ||| NN
,  ||| S:437 E:439 ||| ,
we  ||| S:439 E:442 ||| PRP
will  ||| S:442 E:447 ||| MD
discuss  ||| S:447 E:455 ||| VB
the  ||| S:455 E:459 ||| DT
implication  ||| S:459 E:471 ||| NN
of  ||| S:471 E:474 ||| IN
SIRT6  ||| S:474 E:480 ||| CD
in  ||| S:480 E:483 ||| IN
the  ||| S:483 E:487 ||| DT
biology  ||| S:487 E:495 ||| NN
of  ||| S:495 E:498 ||| IN
cancer  ||| S:498 E:505 ||| NN
and  ||| S:505 E:509 ||| CC
the  ||| S:509 E:513 ||| DT
relevance  ||| S:513 E:523 ||| NN
to  ||| S:523 E:526 ||| TO
organism  ||| S:526 E:535 ||| VB
homeostasis  ||| S:535 E:547 ||| NNS
and  ||| S:547 E:551 ||| CC
lifespan ||| S:551 E:559 ||| NN
.  ||| S:559 E:561 ||| .
